Literature DB >> 33905055

Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema.

Archya Dasgupta1,2,3, Benjamin Geraghty1,2,3, Arjun Sahgal1,2,3, Gregory J Czarnota4,5,6,7, Pejman Jabehdar Maralani8,9, Nauman Malik1,2, Michael Sandhu3, Jay Detsky1,2,3, Chia-Lin Tseng1,2,3, Hany Soliman1,2,3, Sten Myrehaug1,2,3, Zain Husain1,2,3, James Perry10,11, Angus Lau3,12.   

Abstract

PURPOSE: The peritumoral region (PTR) in glioblastoma (GBM) represents a combination of infiltrative tumor and vasogenic edema, which are indistinguishable on magnetic resonance imaging (MRI). We developed a radiomic signature by using imaging data from low grade glioma (LGG) (marker of tumor) and PTR of brain metastasis (BM) (marker of edema) and applied it on the GBM PTR to generate probabilistic maps.
METHODS: 270 features were extracted from T1-weighted, T2-weighted, and apparent diffusion coefficient maps in over 3.5 million voxels of LGG (36 segments) and BM (45 segments) scanned in a 1.5T MRI. A support vector machine classifier was used to develop the radiomics model from approximately 50% voxels (downsampled to 10%) and validated with the remaining. The model was applied to over 575,000 voxels of the PTR of 10 patients with GBM to generate a quantitative map using Platt scaling (infiltrative tumor vs. edema).
RESULTS: The radiomics model had an accuracy of 0.92 and 0.79 in the training and test set, respectively (LGG vs. BM). When extrapolated on the GBM PTR, 9 of 10 patients had a higher percentage of voxels with a tumor-like signature over radiological recurrence areas. In 7 of 10 patients, the areas under curves (AUC) were > 0.50 confirming a positive correlation. Including all the voxels from the GBM patients, the infiltration signature had an AUC of 0.61 to predict recurrence.
CONCLUSION: A radiomic signature can demarcate areas of microscopic tumors from edema in the PTR of GBM, which correlates with areas of future recurrence.

Entities:  

Keywords:  Edema; Glioblastoma multiforme (GBM); Magnetic resonance imaging (MRI); Peritumoral region; Radiomics

Mesh:

Year:  2021        PMID: 33905055     DOI: 10.1007/s11060-021-03762-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging.

Authors:  Takahiro Yamahara; Yoshihiro Numa; Tetsuya Oishi; Takuya Kawaguchi; Toshitaka Seno; Akio Asai; Keiji Kawamoto
Journal:  Brain Tumor Pathol       Date:  2010-11-03       Impact factor: 3.298

2.  Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.

Authors:  Kevin Petrecca; Marie-Christine Guiot; Valerie Panet-Raymond; Luis Souhami
Journal:  J Neurooncol       Date:  2012-10-10       Impact factor: 4.130

Review 3.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

4.  Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.

Authors:  Mark W McDonald; Hui-Kuo G Shu; Walter J Curran; Ian R Crocker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

5.  Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.

Authors:  Ramon F Barajas; Joanna J Phillips; Rupa Parvataneni; Annette Molinaro; Emma Essock-Burns; Gabriela Bourne; Andrew T Parsa; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

Review 6.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

7.  Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.

Authors:  Oliver Eidel; Sina Burth; Jan-Oliver Neumann; Pascal J Kieslich; Felix Sahm; Christine Jungk; Philipp Kickingereder; Sebastian Bickelhaupt; Sibu Mundiyanapurath; Philipp Bäumer; Wolfgang Wick; Heinz-Peter Schlemmer; Karl Kiening; Andreas Unterberg; Martin Bendszus; Alexander Radbruch
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

8.  Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.

Authors:  Alexandre Carré; Guillaume Klausner; Myriam Edjlali; Marvin Lerousseau; Jade Briend-Diop; Roger Sun; Samy Ammari; Sylvain Reuzé; Emilie Alvarez Andres; Théo Estienne; Stéphane Niyoteka; Enzo Battistella; Maria Vakalopoulou; Frédéric Dhermain; Nikos Paragios; Eric Deutsch; Catherine Oppenheim; Johan Pallud; Charlotte Robert
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

Review 9.  Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation.

Authors:  Ahmad Chaddad; Michael Jonathan Kucharczyk; Paul Daniel; Siham Sabri; Bertrand J Jean-Claude; Tamim Niazi; Bassam Abdulkarim
Journal:  Front Oncol       Date:  2019-05-21       Impact factor: 6.244

10.  Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids.

Authors:  Keith M Olson; David I Duron; Daniel Womer; Ryan Fell; John M Streicher
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

View more
  3 in total

1.  Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes.

Authors:  Benjamin J Geraghty; Archya Dasgupta; Arjun Sahgal; Gregory J Czarnota; Michael Sandhu; Nauman Malik; Pejman Jabehdar Maralani; Jay Detsky; Chia-Lin Tseng; Hany Soliman; Sten Myrehaug; Zain Husain; James Perry; Angus Lau
Journal:  J Neurooncol       Date:  2022-01-03       Impact factor: 4.130

Review 2.  The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI Malignancies.

Authors:  Shashank Srinivasan; Archya Dasgupta; Abhishek Chatterjee; Akshay Baheti; Reena Engineer; Tejpal Gupta; Vedang Murthy
Journal:  JCO Glob Oncol       Date:  2022-05

3.  MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region.

Authors:  Nauman Malik; Benjamin Geraghty; Arjun Sahgal; Gregory J Czarnota; Archya Dasgupta; Pejman Jabehdar Maralani; Michael Sandhu; Jay Detsky; Chia-Lin Tseng; Hany Soliman; Sten Myrehaug; Zain Husain; James Perry; Angus Lau
Journal:  J Neurooncol       Date:  2021-10-25       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.